Marian Biotech Articles
Cypress Bioscience goes on a spending spree, gaining rights to autism product and Staccato nicotine technology
27 August 2010
Showing 1-1 of 1 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
